Erythrocyte CD38 as a prognostic marker in cancer

Albeniz I., Demir O., Tuerker-Sener L., Yalçıntepe L., Nurten R., Bermek E.

HEMATOLOGY, vol.12, no.5, pp.409-414, 2007 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 12 Issue: 5
  • Publication Date: 2007
  • Doi Number: 10.1080/10245330701383841
  • Journal Name: HEMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.409-414
  • Istanbul University Affiliated: Yes


Background: Surface antigen CD38 which is a multifunctional protein with enzymatic and receptorial properties is involved in many processes of cell proliferation and activation. It is widely expressed within the hematopoetic system, and its expression is stimulated by proinflammatory cytokines. CD38-associated enzymatic activities in erythrocytes from cancer patients were investigated in this context.